Literature DB >> 9311991

Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product.

D Vallone1, S Battista, G M Pierantoni, M Fedele, L Casalino, M Santoro, G Viglietto, A Fusco, P Verde.   

Abstract

The expression of the high mobility group I (HMGI)-C chromatin component was shown previously to be essential for the establishment of the neoplastic phenotype in retrovirally transformed thyroid cell lines. To identify possible targets of the HMGI-C gene product, we have analyzed the AP-1 complex in normal, fully transformed and antisense HMGI-C-expressing rat thyroid cells. We show that neoplastic transformation is associated with a drastic increase in AP-1 activity, which reflects multiple compositional changes. The strongest effect is represented by the dramatic junB and fra-1 gene induction, which is prevented in cell lines expressing the antisense HMGI-C. These results indicate that the HMGI-C gene product is essential for the junB and fra-1 transcriptional induction associated with neoplastic transformation. The inhibition of Fra-1 protein synthesis by stable transfection with a fra-1 antisense RNA vector significantly reduces the malignant phenotype of the transformed thyroid cells, indicating a pivotal role for the fra-1 gene product in the process of cellular transformation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311991      PMCID: PMC1170163          DOI: 10.1093/emboj/16.17.5310

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  46 in total

1.  Transformation by FosB requires a trans-activation domain missing in FosB2 that can be substituted by heterologous activation domains.

Authors:  R Wisdom; J Yen; D Rashid; I M Verma
Journal:  Genes Dev       Date:  1992-04       Impact factor: 11.361

Review 2.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.

Authors:  P Angel; M Karin
Journal:  Biochim Biophys Acta       Date:  1991-12-10

3.  cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes.

Authors:  G Manfioletti; V Giancotti; A Bandiera; E Buratti; P Sautière; P Cary; C Crane-Robinson; B Coles; G H Goodwin
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

4.  Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity.

Authors:  W J Boyle; T Smeal; L H Defize; P Angel; J R Woodgett; M Karin; T Hunter
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

5.  Elevated high mobility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells.

Authors:  T G Ram; R Reeves; H L Hosick
Journal:  Cancer Res       Date:  1993-06-01       Impact factor: 12.701

6.  Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras.

Authors:  C M Pfarr; F Mechta; G Spyrou; D Lallemand; S Carillo; M Yaniv
Journal:  Cell       Date:  1994-02-25       Impact factor: 41.582

Review 7.  Encounters with Fos and Jun on the road to AP-1.

Authors:  C Abate; T Curran
Journal:  Semin Cancer Biol       Date:  1990-02       Impact factor: 15.707

8.  Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization.

Authors:  Y Tamimi; H G van der Poel; M M Denyn; R Umbas; H F Karthaus; F M Debruyne; J A Schalken
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

9.  The Adenovirus E1A gene blocks the differentiation of a thyroid epithelial cell line, however the neoplastic phenotype is achieved only after cooperation with other oncogenes.

Authors:  M T Berlingieri; M Santoro; C Battaglia; M Grieco; A Fusco
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

10.  Characterization of junD: a new member of the jun proto-oncogene family.

Authors:  S I Hirai; R P Ryseck; F Mechta; R Bravo; M Yaniv
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more
  51 in total

1.  Expression of the high-mobility group protein HMGI(Y) in human trophoblast: potential role in trophoblast invasion of maternal tissue.

Authors:  Ana-Maria Bamberger; Antonis Makrigiannakis; Kerstin Röser; Jessica Radde; Tanja Carstens; Aljoscha M Flohr; Christoph M Bamberger; Jörn Bullerdiek; Thomas Löning
Journal:  Virchows Arch       Date:  2003-09-11       Impact factor: 4.064

2.  Expression of high mobility group A2 is associated with poor survival in hepatocellular carcinoma.

Authors:  Lielin Wu; Zhiming Wang; Rongli Lu; Wei Jiang
Journal:  Pathol Oncol Res       Date:  2012-03-30       Impact factor: 3.201

3.  The PKCθ pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells.

Authors:  K Belguise; S Milord; F Galtier; G Moquet-Torcy; M Piechaczyk; D Chalbos
Journal:  Oncogene       Date:  2012-01-30       Impact factor: 9.867

4.  Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription.

Authors:  Laura Casalino; Latifa Bakiri; Francesco Talotta; Jonathan B Weitzman; Alfredo Fusco; Moshe Yaniv; Pasquale Verde
Journal:  EMBO J       Date:  2007-03-08       Impact factor: 11.598

5.  Binding the mammalian high mobility group protein AT-hook 2 to AT-rich deoxyoligonucleotides: enthalpy-entropy compensation.

Authors:  Suzanne Joynt; Victor Morillo; Fenfei Leng
Journal:  Biophys J       Date:  2009-05-20       Impact factor: 4.033

6.  Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently.

Authors:  Matthew R Young; Rajalakshmi Nair; Natalie Bucheimer; Preety Tulsian; Nicole Brown; Cristi Chapp; Tin-Chen Hsu; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

7.  The High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression.

Authors:  Paula Mussnich; Daniela D'Angelo; Vincenza Leone; Carlo Maria Croce; Alfredo Fusco
Journal:  Mol Oncol       Date:  2013-01-17       Impact factor: 6.603

8.  Role of mitogen-activated protein kinases (MAPK) in cell injury and proliferation by environmental particulates.

Authors:  Maria E Ramos-Nino; Astrid Haegens; Arti Shukla; Brooke T Mossman
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

9.  Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas.

Authors:  B Mann; M Gelos; A Siedow; M L Hanski; A Gratchev; M Ilyas; W F Bodmer; M P Moyer; E O Riecken; H J Buhr; C Hanski
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  Gene expressions of HMGI-C and HMGI(Y) are associated with stage and metastasis in colorectal cancer.

Authors:  Meng-Lin Huang; Chou-Chan Chen; Li-Ching Chang
Journal:  Int J Colorectal Dis       Date:  2009-07-17       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.